Centre de référence des syndromes neurologiques paranéoplasiques et encéphalites autoimmunes
Lyon, 69677, France
NCT Number: NCT05645185
Paraneoplastic neurological syndromes (PNS) are rare complications of cancer occurring in 0.01% of cases. Their clinical, biological and radiological presentation is heterogeneous and may constitute a diagnostic challenge. Anti-Ma2 PNS are rare diseases with a guarded prognosis. They are most often associated with a seminoma-like testicular tumor but can also be associated with lung cancer. Classically, they present as limbic, diencephalic and/or brainstem encephalitis. Anti-Ma2 antibodies target intracellular receptors and are characteristic of a particular form of encephalitis. Atypical manifestations including narcolepsy-cataplexy, weight gain, sexual dysfunction and motor neuron syndrome have been described and explain the difficulty in diagnosing anti-Ma2 associated PNS. It seems interesting to better characterize the phenotypes of Ma2 patients in order to optimize the diagnosis and follow-up.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Lyon, 69677, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Tests can be used: immunofluorescence, immunodot, western blot, tests CBA on sera or CSF.
Time frame: 12 month after diagnosis
Follow up and survival (rankin score)
Hospices Civils de Lyon
Other
Acronym: CarMa2
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07722286
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Hangzhou, Zhejiang, China
View Trial DetailsNCT06753955
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Melbourne, Victoria, Australia
View Trial DetailsNCT06575153
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Melbourne, Victoria, Australia
View Trial DetailsNCT06609044
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Bron, France
View Trial Details